BusinessCloud is counting down the technology which could save your life this week and next.
One of the key areas of healthcare is ensuring that patients are taking the medicines they’re prescribed – which is where eLucid mHealth comes in.
Established in 2013 by Farid Khan and Graham Howieson, the duo aimed to bring together Howieson’s experience in clinical trial packaging and supply and Khan’s bio-tech research.
Dr James Burnstone joined as CTO a year later to provide the technology and engineering expertise.
eLucid’s main product is Med eBottle, an intelligent pill bottle.
Together with a mobile app and cloud-based system, the tool can monitor a person’s medicine use in real time.
The bottle effectively knows the identity of its user and when it should and shouldn’t be used. It can alert medical staff if the medication is taken incorrectly.
“It’s like having a little doctor with you all the time helping you take care of your medicine use,” explains Burnstone.
The product is still currently in the development phase.
Studies and clinical trials are currently being organised to collect data about how people feel using it.
“We are also part of an NHS testbed based in Surrey and East Hampshire borders,” says Burnstone.
“We are testing our products as part of an Internet of Things consortium with other great med tech companies; the study is based around patients with dementia and building a connected IoT health care system in the home.”
eLucid, based at Manchester Science Partnership, is currently putting together plans for its next work and recently closed a funding round.
We reported on Monday how Skin Analytics is a tool which aims to improve the survival rate for melanoma skin cancer by providing users with a low-cost way to identify moles which could be cancerous.
On Tuesday we brought you Florence, a telecom-based tech is looking to reduce hospital admissions and keep people in their homes for longer.
On Wednesday we featured Dublin-based start-up Beats Medical, which helps to improve the lives of those with Parkinson’s disease.
And on Thursday we reported on Eva Diagnostics, a company whose aim is to revolutionise blood tests so they can be analysed without a hospital laboratory – potentially improving the lives of people undergoing chemotherapy.